Gabor Brasnjo, Ph.D.
About Gabor Brasnjo, Ph.D.
Gabor Brasnjo, Ph.D., serves as the Senior Director of Intellectual Property at Sangamo Therapeutics, Inc., where he leverages his extensive background in neuroscience and law to manage intellectual property in biotechnology. His career includes roles at various prestigious organizations, including Zymergen, FisherBroyles, and Wilson Sonsini Goodrich & Rosati, and he possesses significant expertise in genome editing technologies.
Current Role at Sangamo Therapeutics
Gabor Brasnjo, Ph.D. serves as the Senior Director of Intellectual Property at Sangamo Therapeutics, Inc. since 2022. In this role, he oversees the management and strategy of intellectual property assets related to therapeutic compositions and regimens. His position builds on his previous experience at Sangamo, where he was the Director of Intellectual Property from 2020 to 2022. His work in the San Francisco Bay Area focuses on the intersection of biotechnology and legal frameworks.
Previous Experience in Intellectual Property Law
Prior to his current role, Gabor Brasnjo worked at Zymergen, Inc. as a Patent Attorney from 2018 to 2019. He also held positions at Wilson Sonsini Goodrich & Rosati as an Associate from 2016 to 2017 and at Arnold & Porter LLP as an Associate from 2013 to 2016. His legal career includes a summer associate position at Arnold & Porter LLP in 2012 and a legal internship at the UCSF Office of Innovation, Technology & Alliances in the same year. This extensive experience in intellectual property law supports his current responsibilities.
Educational Background and Expertise
Gabor Brasnjo holds a J.D. from the University of California, College of the Law, San Francisco (formerly UC Hastings), achieved from 2010 to 2013. He completed his postdoctoral studies in Neuroscience at Stanford University from 2006 to 2010 and holds a Ph.D. in Neurobiology from UCLA, where he studied from 1998 to 2004. His educational background also includes a postdoctoral fellowship in Neurobiology and Biochemistry at Cornell University from 2004 to 2006 and a B.S. in Cell & Molecular Biology and Chemistry from San Francisco State University.
Scientific and Legal Expertise
Gabor Brasnjo possesses scientific expertise in brain physiology and neurobiology, which enhances his legal work in intellectual property. He has extensive experience in technologies related to genome editing and modulation, crucial for personalized medicine. His background in general and organic chemistry supports his patent prosecution and strategic patent counseling in industrial chemistry innovations. Additionally, his knowledge of automation technologies is significant in managing intellectual property in increasingly automated sectors.
Research and Academic Contributions
Gabor Brasnjo's academic contributions include research roles at prestigious institutions. He was a Postdoctoral Associate at Weill Cornell Medical College from 2004 to 2006 and a Graduate Student & Researcher at UCLA from 1998 to 2004. He has also participated in advanced studies at Cold Spring Harbor Laboratory, focusing on Advanced Microscopy and Imaging, as well as Cell & Molecular Biology. His research experience complements his legal expertise in biotechnology and intellectual property.